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Rapidly increasing resistance to currently available HIV-1 drugs has prompted the exploration of 
therapies less susceptible to resistance development. Anti-HIV-1 treatments often target reverse 
transcriptase (RT), the viral protein that polymerizes the integrated DNA copy of the viral RNA 
genome. For many such drugs, resistance requires only a few amino acid changes in the RT 
protein. Aptamers are small, single stranded nucleic acids that form unique three-dimensional 
structures allowing specific binding to molecular targets. When bound to proteins, aptamers 
often hinder their native function. RNA and DNA aptamers that bind to viral proteins and inhibit 
HIV-1 at several stages of infection have been isolated. Burke et al, (1996) have proposed that 
variability in anti-RT aptamer structures may overcome the development of resistance because 
of different contacts with the RT protein.  Here, multiple anti-HIV-1 RT RNA aptamers (118 or 
134 nucleotides in length) were screened for inhibition of RT-catalyzed DNA polymerization. 
Aptamer inhibition of RT activity was measured using an HIV-derived synthetic template and 
fluorescently-labeled primers, and by quantifying the amount of fully extended primer. Sixty-two 
aptamers were screened and grouped according to inhibition performance. In the “BEST” 
category, twenty-two aptamers displayed ~100 percent inhibition at the highest aptamer 
concentration (100 nM) and half-maximal inhibition (IC50) values of less than 3 nM. The “VERY 
GOOD” category contains twenty aptamers with greater than 90 percent inhibition at the highest 
concentration and IC50 values between 3 nM and 9.5 nM. Of the remaining samples, 
“MODEST” aptamers yielded 25 to 80 percent inhibition and “POOR” aptamers showed less 
than 20 percent inhibition at the highest aptamer concentration. Furthermore, sequence and 
structural analyses may reveal variations in the aptamer-protein interaction between potent 
aptamers. These data may define the critical interactions between the aptamer and RT, 
increasing inhibition potency while reducing susceptibility to resistance. 
  
